Medical News

RSS

REPLICor to disclose unique antiviral drug

REPLICor Inc., a privately owned biopharmaceutical company, is developing a broad spectrum antiviral drug called REP 9 which has the broadest spectrum of activity in vitro ever reported for a single chemical entity.

30 Mar 2005

Hemodialysis causes antioxidant loss leading to long-term complications

An article published in Hemodialysis International discusses the role of oxidative stress (OS) in dialysis patients, an imbalance which can result in long-term health problems. Potential therapeutic options to restore balance in patients are also reviewed.

30 Mar 2005

Device may offer alternative for stroke patients

As the most common cause of adult disability in the United States, stroke leaves many survivors unable to perform tasks that were once part of their daily routine. Much of the time the disabilities are treatable, but the high cost of rehabilitation therapy leaves many patients to cope on their own.

30 Mar 2005

Pope John Paul II may need to be fed intravenously

The Pope apparently has had difficulty swallowing since a breathing tube was inserted late February.

30 Mar 2005

Avoiding risks of skin cancer from ultraviolet radiation (UVR)

Cancer Research UK has launched the SunSmart Campaign for 2005 and NRPB strongly supports the health promotion messages in the campaign.

30 Mar 2005

Protein Mnd2 protects chromosome bonds

The protein Mnd2 inhibits premature separation of chromosomes during the formation of gametes. The now published discovery of this regulatory function may help to understand the origin of some common congenital chromosome defects.

30 Mar 2005

High-rise homes have the highest levels of cockroach allergens

Roaches like to live high in the sky in places like Chicago, New York City and the Bronx, according to a recent study in the Journal of Allergy and Clinical Immunology. The study, conducted by an allergist affiliated with Children's Medical Center Dallas, found high-rise homes in Northeastern cities had the highest levels of cockroach allergens -- leading to a higher incidence of asthmatic episodes.

30 Mar 2005

$20 billion in cardiovascular drug revenues soon subject to patent expiration

More than $20 billion in major cardiovascular drug revenues will be exposed to patent expiration in the next three to five years, according to a report by business intelligence firm Cutting Edge Information.

30 Mar 2005

Favorable Austrian ruling for Ranbaxy on Atorvastatin

Ranbaxy Pharmaceuticals, Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Ltd (Ranbaxy), hasy announced that it successfully invalidated claims 1-3 (all claims sought to be invalidated) of Austrian Patent No. AT E 207 896 as anticipated by, and as lacking inventive step over, respectively, a Pfizer-owned published patent application and a Pfizer owned patent, as reflected by a decision released by the Austrian Patent Office.

30 Mar 2005

Pfizer awarded injunction blocking Teva/Ranbaxy from selling generic Quinapril

Pfizer Inc has obtained a preliminary injunction halting sales of a generic quinapril product marketed by Teva Pharmaceuticals USA Inc., Ranbaxy Pharmaceuticals Inc., and Ranbaxy Laboratories Limited.

30 Mar 2005

280 million pound package to transform the quality of school meals

Britain's Education Secretary Ruth Kelly today set down that schools should spend at least 50p per child on food ingredients as she unveiled a £280 million package to transform the quality of school meals.

30 Mar 2005

Conventional wisdom could be wrong in primary care

A study by Mark Hall, J.D., professor of law and public health sciences at Wake Forest University Baptist Medical Centre, is suggesting that conventional wisdom could be wrong in that primary care doctors who coordinate the care of their patients by specialists may actually have lower liability risk than primary care doctors who do not attempt care coordination.

29 Mar 2005

Lip piercing bad for gums

Researchers from Ohio State University - in a study of 58 young adults have found that having a lip piercing is bad for the gums and can make them shrink back from the teeth. The researchers also warn the longer people wear the piercing, the worse the recession.

29 Mar 2005

Smack that bottom - it can cure everything !!

Russian scientists at the Novosibirsk Institute of Medicine are claiming a beating on the naked buttocks with a cane is the perfect way to cure everything from depression to alcoholism.

29 Mar 2005

Exercise may be best treatment for depression

The Mental Health Foundation in it's report - "Up and Running", says exercise might well prove to be a more effective treatment for some forms of depression than pills, and GPs should be offering all patients with depression a programme of exercise to help overcome their symptoms.

29 Mar 2005

Vets need to take more precautions over MRSA

The British Veterinary Association (BVA) has warned that vets should take hospital-style precautions to avoid passing the MRSA "superbug" to animals, and should use sterile gloves, scrub suits and masks during operations to protect the animals.

29 Mar 2005

Pharmaceutical reproductive rights in the United States

The battle over reproductive rights in the United States has taken another turn with some pharmacists refusing to fill prescriptions for birth control and morning-after pills on the grounds that dispensing the medications violates their moral or religious beliefs.

29 Mar 2005

Clinical study of mirror neurons provides insights into autism and other disorders

Seeing is doing – at least it is when mirror neurons are working normally. But in autistic individuals, say researchers from the University of California, San Diego, the brain circuits that enable people to perceive and understand the actions of others do not behave in the usual way.

29 Mar 2005

Coordinating care of chronically ill patients does not increase liability

Conventional wisdom is wrong: primary care doctors who coordinate the care of their patients by specialists may actually have lower liability risk than primary care doctors who do not attempt care coordination.

29 Mar 2005

Vical Incorporated issued two Canadian patents

Vical Incorporated announced today the issuance of two Canadian patents on the company's core technology, which involves direct administration of polynucleotide genetic material such as DNA or RNA.

29 Mar 2005